Skip to content
    LSP (EQT Life Sciences) logo

    LSP (EQT Life Sciences)

    Amsterdam, NetherlandsFounded 1987
    eqtgroup.com/en/private-capital/eqt-life-sciencesLinkedIn
    Biotech & Life SciencesHealthcare

    EQT Life Sciences (formerly LSP / Life Sciences Partners) is one of Europe's largest and most experienced life sciences venture capital firms, investing in innovative companies focused on therapeutics, medical devices, diagnostics, and healthtech. Founded in 1987 and headquartered in Amsterdam, it was acquired by EQT in March 2022 and renamed EQT Life Sciences.

    51% of their portfolio is in Biotech & Life Sciences. Deal activity increased 171% year-over-year (19 deals in the last 12 months). Average disclosed round size is $78.0M (across 53 rounds with reported amounts).

    Find people at LSP (EQT Life Sciences) on Goldilocks AI

    Portfolio

    56

    Fund Size

    $1.1B

    Top Stage

    Series B

    Last 12 Mo

    14

    Team

    RF

    Roberta Ferrari

    Managing Director

    CB

    Christoph Broja

    Partner

    AR

    Abhiram Rao

    Director

    LG

    Laurenz Govaerts

    Director

    KH

    Kevin Hammon

    Vice President

    MM

    Maximilian Moser

    Vice President

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    70 investments
    CompanyRoundAmountDate
    RQ Bio logoRQ BioSeries A$115MJun 2026
    Neurent Medical logoNeurent MedicalSeries C$74MFeb 2026
    Aerska logoAerskaSeries A$39MFeb 2026
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries B$85MJan 2026
    Exciva logoExcivaSeries B—Jan 2026
    Kinaset Therapeutics logoKinaset TherapeuticsSeries B$103MJan 2026
    RRq Biotechnology LtdSeries A$115MJan 2026
    FoRx Therapeutics logoFoRx TherapeuticsSeries A$50MDec 2025
    Xeltis logoXeltisGrowth—Dec 2025
    Artios Pharma logoArtios PharmaSeries D$115MNov 2025
    AArtiosSeries D$115MNov 2025
    Electra logoElectraSeries C$183MOct 2025
    EElectra TherapeuticsSeries C$183MOct 2025
    Tubulis logoTubulisSeries C—Oct 2025
    ViCentra logoViCentraSeries D$85MSep 2025
    CCyted HealthSeries B$44MSep 2025
    Neuros Medical logoNeuros MedicalSeries D$56MJul 2025
    Neuros logoNeurosSeries D$56MJul 2025
    SpliceBio logoSpliceBioSeries B$135MJun 2025
    SSplice BioSeries B$135MJun 2025
    Mosanna Therapeutics logoMosanna TherapeuticsSeries A$80MJun 2025
    Atalanta Therapeutics logoAtalanta TherapeuticsSeries B$75MJan 2025
    Exciva logoExcivaSeries B$59MJan 2025
    XyloCor Therapeutics logoXyloCor TherapeuticsSeries B$67.5MJan 2025
    SNIPR Biome logoSNIPR BiomeSeries B$40MJan 2025
    Page 1 of 3

    Top Co-Investors

    Andera Partners14 shared
    M Ventures8 shared
    Sofinnova Partners8 shared
    Pfizer Ventures7 shared
    Sanofi Ventures7 shared
    RA Capital Management7 shared
    SV Health Investors6 shared
    Novartis Pharma AG6 shared
    The Invus Group, LLC6 shared
    Kurma Partners6 shared
    Gimv6 shared
    Fountain Healthcare Partners6 shared
    IP Group plc5 shared
    Pivotal Life Sciences5 shared
    Schroders Capital5 shared
    Invest-NL5 shared
    Sectoral Asset Management5 shared
    Scale Venture Partners4 shared
    Aperture Venture Partners4 shared
    Omega Funds4 shared

    Last updated: 7 September 2026